Device Tax Repeal: Questions On Offsets, Senate Votes
This article was originally published in The Gray Sheet
Executive Summary
Cook Medical Chairman Steve Ferguson says any potential offset of the medical device tax would likely be a non-partisan pay-for that could include raising money from savings in other parts of the budget or unexpended funds. Some industry advocates question whether an offset will actually be necessary.
You may also be interested in...
Industry Groups Tag-Team To Attack Device Tax
AdvaMed and MDMA simultaneously released survey results from their member companies arguing the tax has hurt jobs and investment in the industry and will continue to do so if it is not repealed.
‘Parity To The Originator Is Not Enough’ – Cardinal Health Talks US Biosimilars
Following what Cardinal Health described as “a year of monumental developments in biosimilars,” the firm’s director of biosimilars, Dracey Poore, spoke to Generics Bulletin for an exclusive Q&A.
Fresenius And Formycon Strike Stelara Settlement For Europe And Canada
Partners Fresenius Kabi and Formycon have laid the groundwork to launch their biosimilar ustekinumab rival to Stelara in Europe and Canada through a settlement agreement with originator J&J.